RADIOPHARMACEUTICALS (LUTATHERA and PLUVICTO)

Closed Special Notice Posted

A later notice was posted: the Limited / Sole Source Justification from .

Solicitation number
W81K0024R0020
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Jbsa Ft Sam Houston, Texas 78234, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of the Army Medical Command (MEDCOM) has published a Special Notice for a sole source contract to purchase two FDA-approved radiopharmaceutical products, Lutetium Lu-177 Dotatate (Lutathera) and Lutetium Lu-177 Vipivotide Tetraxetan (Pluvicto), from the manufacturer Advanced Accelerator Applications USA (AAA). The Department of Nuclear Medicine Service at Brooke Army Medical Center (BAMC) requires these products for the imaging and treatment of somatostatin receptor-positive gastroeteropancreatic neuroendocrine tumors and for the treatment of adult patients with prostatic-specific membrane antigen-positive metastatic castration-resistant prostate cancer.

The purpose of this Special Notice is to inform potential vendors of the government's intent to award a sole source contract to AAA for the supply of these radiopharmaceuticals over a 5-year ordering period from October 2024 to September 2029. The quantities required during this period are specified in the notice. While this is not a request for quotations, any vendor that believes it can provide the stated supplies may submit a capability statement. Verbal responses will not be considered. The NAICS code is 325412 Pharmaceutical Preparation Manufacturing, with a size standard of 1,300 employees.

Notice text

Notice of Intent for Solicitation: W81K0024R0020

The Medical Readiness Contracting Office-West intends to award a sole source contract to Advanced Accelerator Applications USA (AAA), for 2 FDA approved radiopharmaceuticals of which they are the manufacturer.

The Department of Nuclear Medicine Service at Brooke Army Medical Center (BAMC) requires two Food and Drug Administration (FDA) approved products that are required for the imaging and treatment of somatostatin receptor-positive gastroeteropancreatic neuroendocrine tumors and for the treatment of adult patients with prostatic-specific membrane antigen-positive metastatic castration-resistant prostate cancer. NAICS: 325412 Pharmaceutical Preparation Manufacturing; Size Standard 1,300.

The following are description of items and quantities:

Lutetium Lu-177 Dotatate (Lutathera)

Lutetium Lu-177 Vipivotide Tetraxetan (Pluvicto)

Ordering Period                                                                     LUTATHERA qty          PLUVICTO qty

Ordering Period 1: 1 October 2024 - 30 September 2025                     31                         108

Ordering Period 2: 1 October 2025 - 30 September 2026                     30                         108

Ordering Period 3: 1 October 2026 - 30 September 2027                     30                         120

Ordering Period 4: 1 October 2027 - 30 September 2028                     30                         120

Ordering Period 5: 1 October 2028 - 30 September 2029                     30                         140

This notice of intent is not a request for quotations and a solicitation will not be issued in conjunction with the notice of intent. Any vendor that believes it can provide the stated supplies may provide a capability statement. Verbal responses are not acceptable and will not be considered.

Notice history

Notice Type Posted
RADIOPHARMACEUTICALS (LUTATHERA and PLUVICTO) Latest Limited / Sole Source Justification
This notice Latest special notice Special Notice
RADIOPHARMACEUTICALS (LUTATHERA and PLUVICTO) Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--INTENT TO SOLE SOURCE Radiopharm - Lutathera & Pluvicto - Lebanon VAMC NAICS 325412 Veterans Integrated Service Network 4 No set-aside
6505--VA Long Beach Pylarify NAICS 325412 Veterans Integrated Service Network 22 No set-aside
6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 See Section 11 of the Cleveland and Kent, Ohio, United States · NAICS 325412 Veterans Integrated Service Network 10 No set-aside
Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. Medical Command No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors